High-throughput screening

InhibOx CEO explains to IPT why cloud computing will revolutionise Drug Discovery

Submitted by InhibOx on June 17, 2010 - 10:37

InhibOx CEO Paul Davie talks to Innovations in Pharmaceutical Technology about how cloud computing is set to transform drug discovery.

Download the full article here, or visit the IPT online website to view the June edition of the journal.

Cloud
High-throughput screening

InhibOx and Molport Join Forces to Deliver Integrated Lead Design and Delivery

Submitted by InhibOx on December 3, 2009 - 16:00

Oxford, UK — 3rd December 2009

InhibOx Ltd (Oxford, UK) and MolPort Ltd (Riga, Latvia) announce a strategic partnership to deliver integration in library design and compound provision.